UK Companies House feature
HVL PHARMA UK LTD
Cash
£471K
+3,523.1% vs 2020
Net assets
£42M
-75.1% vs 2020
Employees
227
+4.1% vs 2020
Profit before tax
£12M
+130.8% vs 2020
Profile
- Company number
- 01556886
- Status
- Active
- Incorporation
- 1981-04-21
- Last accounts made up
- 2024-12-30
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Net assets
3-year trend · vs UK Healthcare median
Accounts
3-year trend · latest 2021-12-31
| Metric | Trend | 2020-01-01 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Turnover | — | £62,596,000 | £64,843,000 | |
| Operating profit | — | £5,307,000 | £11,672,000 | |
| Profit before tax | — | £5,370,000 | £12,393,000 | |
| Net profit | — | £3,827,000 | £8,829,000 | |
| Cash | — | £13,000 | £471,000 | |
| Total assets less current liabilities | — | £173,052,000 | £48,035,000 | |
| Net assets | — | £167,718,000 | £41,733,000 | |
| Equity | £168,736,000 | £167,718,000 | £41,733,000 | |
| Average employees | — | 218 | 227 | |
| Wages | — | £11,470,000 | £11,330,000 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- BDO LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have reviewed the company's forecast cash flows for a period of at least 12 months from the date of approval of these financial statements, which show that the Company is expected to generate cash inflows (with the support of cash injections from the parent company). The Company's cash position is managed locally by the financial team. The Directors have received confirmation from its ultimate holding company, Particle Dynamics Holdings, Inc of its intention to provide such financial support as the Company requires for a period of at least 12 months from the date of approval of the financial statements. Based on current forecasts and strategic developments, the Directors consider that the longer-term going concern risk is low, and they expect the Company to return to profitability in due course.”
Significant events
- “The Directors identify the primary risk and uncertainty as potential disruptions to the Company's product supply and its own manufacturing and processing facilities. Increasing generic competition for the two main products manufactured by the Company is impacting demand and creating uncertainty in the medium to longer term.”
- “The Company is exposed to foreign exchange risk due to the mismatch between its revenue and cost base, with most of the income denominated in euros (EUR) and most expenses incurred in pounds sterling (GBP).”
- “A major investment has been undertaken in 2023 to install a 1.6 MW solar farm on the site on Rookwood Way, this was operational in early 2024.”
- “On 30 June 2025, the Company was successfully sold to a US based company called Particle Dynamics. Particle Dynamics is a global leader in particle processing and delivery technologies.”
- “On 22 September 2025 the name of the Company was changed from EuroAPI UK Limited to HVL Pharma UK Ltd.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 49 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FORTIN, Nicolas | Director | 2025-06-30 | Nov 1974 | Canadian |
| HODGSON, Nicholas James | Director | 2025-07-16 | Nov 1978 | British |
| KANAN, Michael Forrest | Director | 2025-07-16 | Feb 1963 | American |
Show 49 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BRYAN, Christopher John | Secretary | 2005-10-31 | 2007-02-23 |
| CALDERBANK, Andrew Charles | Secretary | 1995-04-28 | 1996-01-12 |
| CHAMBERLAIN, Ian Philip | Secretary | 1996-01-12 | 1998-05-06 |
| COLLIVER, Valerie Anne | Secretary | 2007-02-23 | 2013-05-29 |
| COX, Sara | Secretary | 2013-05-29 | 2024-12-20 |
| HARROW, Terence Alfred, Dr | Secretary | 1999-03-11 | 2005-10-31 |
| MODI, Vishal | Secretary | 2024-12-20 | 2025-06-30 |
| PARISH, Ian Maxwell | Secretary | — | 1995-04-28 |
| SMITH, Christopher Robert | Secretary | 1998-05-06 | 1998-05-06 |
| BAKER, Gary | Director | 2023-09-27 | 2025-03-01 |
| BAMFORTH, Mark Robert | Director | 1997-10-09 | 2010-03-01 |
| BARKER, Richard Charles | Director | 1995-06-29 | 1998-01-16 |
| BRYAN, Christopher John | Director | 2021-12-13 | 2024-08-01 |
| BRYAN, Christopher John | Director | 2001-11-27 | 2017-02-17 |
| BUSH, David Anthony, Dr | Director | 1995-06-29 | 2005-04-08 |
| CAROLAN, Dominic Joseph | Director | 2009-06-23 | 2014-07-31 |
| CASPANI, Michael Martin | Director | 2025-06-30 | 2025-07-16 |
| CORTINOVIS, Matthieu Jean | Director | 2012-10-16 | 2014-11-19 |
| CORTVRIEND, Martin John | Director | 1999-11-02 | 2000-09-05 |
| COUSINS, Simon John, Dr | Director | 2000-09-05 | 2009-11-01 |
| COX, Geoffrey Frank, Dr | Director | — | 1997-09-29 |
| COX, Sara | Director | 2024-08-01 | 2025-06-30 |
| DROHAN, Paul Victor | Director | 2005-07-20 | 2006-05-25 |
| DUHALDE, Francois Xavier | Director | 2016-06-08 | 2021-03-31 |
| EDWARDS, Paul Martin | Director | 1993-04-19 | 1998-01-12 |
| GAMSTON, John | Director | 2011-12-19 | 2014-01-15 |
| GERAGHTY, James A | Director | 1998-05-06 | 1999-11-02 |
| HALE, Arthur James, Doctor | Director | — | 1993-12-31 |
| HENNECKE, Derek George | Director | 2025-06-30 | 2025-07-16 |
| HODGSON, Nicholas James | Director | 2024-08-01 | 2025-06-30 |
| HODGSON, Nick | Director | 2014-09-24 | 2015-10-13 |
| INCERTI, Carlo, Dr | Director | 2004-11-30 | 2006-05-25 |
| JOHNSON, Malcolm David | Director | 2000-09-05 | 2006-01-25 |
| KHAN, Usman | Director | 2021-03-31 | 2021-12-13 |
| KIRKPATRICK, Shaun Alexander | Director | 2025-06-30 | 2025-07-16 |
| LEIGH PEMBERTON, Jeremy | Director | — | 1993-12-31 |
| LOGUE, Paul | Director | 2010-02-23 | 2011-12-19 |
| MCLACHLAN, David John | Director | 1991-09-13 | 1999-11-02 |
| MORETTA, James | Director | 2015-05-14 | 2023-09-27 |
| MORRIS, Steven | Director | 1998-05-06 | 2000-10-23 |
| O'CONNOR, Paul John | Director | 2005-04-01 | 2007-11-26 |
| OLLINGTON, James Frank, Dr | Director | 1997-10-09 | 2000-07-07 |
| PARISH, Ian Maxwell | Director | — | 1995-04-28 |
| POGORZELSKI, Donald | Director | 2000-07-07 | 2010-12-22 |
| POWER, John Anthony, Dr | Director | 2007-11-26 | 2010-12-22 |
| PROSSER, Andy | Director | 2015-05-14 | 2016-06-08 |
| SMITH, Paul Derek | Director | 2014-09-24 | 2015-10-13 |
| TERMEER, Henri Adrianus | Director | — | 1999-11-02 |
| VAN HEEK, Gerrit Jan | Director | 1991-02-01 | 1997-10-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Haverhill Uk Holdco Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-06-30 | Active |
| Euroapi | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-05-06 | Ceased 2025-06-30 |
| Sanofi | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2022-05-06 |
Filing timeline
Last 20 of 264 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-02-04 | RP01SH01 | miscellaneous | legacy |
| 2025-12-24 | SH01 | capital | capital allotment shares |
| 2025-10-28 | SH01 | capital | capital allotment shares |
| 2025-10-10 | ANNOTATION | miscellaneous | legacy |
| 2025-10-07 | AA | accounts | accounts with accounts type full |
| 2025-09-22 | CERTNM | change-of-name | certificate change of name company |
| 2025-08-26 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-08-06 | RESOLUTIONS | resolution | resolution |
| 2025-08-06 | MA | incorporation | memorandum articles |
| 2025-07-16 | AP01 | officers | appoint person director company with name date |
| 2025-07-16 | AP01 | officers | appoint person director company with name date |
| 2025-07-16 | TM01 | officers | termination director company with name termination date |
| 2025-07-16 | TM01 | officers | termination director company with name termination date |
| 2025-07-16 | TM01 | officers | termination director company with name termination date |
| 2025-07-02 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-07-02 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-07-02 | TM01 | officers | termination director company with name termination date |
| 2025-07-02 | TM01 | officers | termination director company with name termination date |
| 2025-07-02 | TM02 | officers | termination secretary company with name termination date |
| 2025-07-02 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ (private-firm) · reference 2021-12-31
2.18
GREY ZONE
Altman Z″
- Working capital / Total assets 0.025 × 6.56 = +0.16
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.141 × 6.72 = +0.95
- Book equity / Total liabilities 1.016 × 1.05 = +1.07
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory